BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15607792)

  • 1. Lymphotoxin alpha 1 beta 2: a critical mediator in V alpha 14i NKT cell differentiation.
    Franki AS; Van Beneden K; Dewint P; Meeus I; Veys E; Deforce D; Elewaut D
    Mol Immunol; 2005 Feb; 42(4):413-7. PubMed ID: 15607792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NIK-dependent RelB activation defines a unique signaling pathway for the development of V alpha 14i NKT cells.
    Elewaut D; Shaikh RB; Hammond KJ; De Winter H; Leishman AJ; Sidobre S; Turovskaya O; Prigozy TI; Ma L; Banks TA; Lo D; Ware CF; Cheroutre H; Kronenberg M
    J Exp Med; 2003 Jun; 197(12):1623-33. PubMed ID: 12810685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential requirement for Rel/nuclear factor kappa B family members in natural killer T cell development.
    Sivakumar V; Hammond KJ; Howells N; Pfeffer K; Weih F
    J Exp Med; 2003 Jun; 197(12):1613-21. PubMed ID: 12810684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The unconventional role of LT alpha beta in T cell differentiation.
    Elewaut D; Ware CF
    Trends Immunol; 2007 Apr; 28(4):169-75. PubMed ID: 17336158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the lymphotoxin beta receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells.
    Degli-Esposti MA; Davis-Smith T; Din WS; Smolak PJ; Goodwin RG; Smith CA
    J Immunol; 1997 Feb; 158(4):1756-62. PubMed ID: 9029113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system.
    Warzocha K; Bienvenu J; Coiffier B; Salles G
    Eur Cytokine Netw; 1995; 6(2):83-96. PubMed ID: 7578992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential activities of secreted lymphotoxin-alpha3 and membrane lymphotoxin-alpha1beta2 in lymphotoxin-induced inflammation: critical role of TNF receptor 1 signaling.
    Sacca R; Cuff CA; Lesslauer W; Ruddle NH
    J Immunol; 1998 Jan; 160(1):485-91. PubMed ID: 9552007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors.
    Browning JL; Dougas I; Ngam-ek A; Bourdon PR; Ehrenfels BN; Miatkowski K; Zafari M; Yampaglia AM; Lawton P; Meier W
    J Immunol; 1995 Jan; 154(1):33-46. PubMed ID: 7995952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic evidence supporting selection of the Valpha14i NKT cell lineage from double-positive thymocyte precursors.
    Egawa T; Eberl G; Taniuchi I; Benlagha K; Geissmann F; Hennighausen L; Bendelac A; Littman DR
    Immunity; 2005 Jun; 22(6):705-16. PubMed ID: 15963785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes.
    Browning JL; Sizing ID; Lawton P; Bourdon PR; Rennert PD; Majeau GR; Ambrose CM; Hession C; Miatkowski K; Griffiths DA; Ngam-ek A; Meier W; Benjamin CD; Hochman PS
    J Immunol; 1997 Oct; 159(7):3288-98. PubMed ID: 9317127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of TNF ligand and receptor family in the lymphoid organogenesis defined by gene targeting.
    Matsumoto M
    J Med Invest; 1999 Aug; 46(3-4):141-50. PubMed ID: 10687308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rel/NF-kappaB family member RelA regulates NK1.1- to NK1.1+ transition as well as IL-15-induced expansion of NKT cells.
    Vallabhapurapu S; Powolny-Budnicka I; Riemann M; Schmid RM; Paxian S; Pfeffer K; Körner H; Weih F
    Eur J Immunol; 2008 Dec; 38(12):3508-19. PubMed ID: 19003818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes.
    Mackay F; Bourdon PR; Griffiths DA; Lawton P; Zafari M; Sizing ID; Miatkowski K; Ngam-ek A; Benjamin CD; Hession C; Ambrose CM; Meier W; Browning JL
    J Immunol; 1997 Oct; 159(7):3299-310. PubMed ID: 9317128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic expression of the tumor necrosis factor family member lymphotoxin-beta is regulated by interleukin (IL)-6 and IL-1beta: transcriptional control mechanisms in oval cells and hepatoma cell lines.
    Subrata LS; Lowes KN; Olynyk JK; Yeoh GC; Quail EA; Abraham LJ
    Liver Int; 2005 Jun; 25(3):633-46. PubMed ID: 15910501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for lymphotoxin in the acquisition of Ly49 receptors during NK cell development.
    Lian RH; Chin RK; Nemeth HE; Libby SL; Fu YX; Kumar V
    Eur J Immunol; 2004 Oct; 34(10):2699-707. PubMed ID: 15368286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphotoxin and LIGHT signaling pathways and target genes.
    Schneider K; Potter KG; Ware CF
    Immunol Rev; 2004 Dec; 202():49-66. PubMed ID: 15546385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proinflammatory responses are efficiently induced by homotrimeric but not heterotrimeric lymphotoxin ligands.
    Hochman PS; Majeau GR; Mackay F; Browning JL
    J Inflamm; 1995-1996; 46(4):220-34. PubMed ID: 8878796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling through the lymphotoxin-beta receptor stimulates HIV-1 replication alone and in cooperation with soluble or membrane-bound TNF-alpha.
    Marshall WL; Brinkman BM; Ambrose CM; Pesavento PA; Uglialoro AM; Teng E; Finberg RW; Browning JL; Goldfeld AE
    J Immunol; 1999 May; 162(10):6016-23. PubMed ID: 10229841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal cryptopatch formation in mice requires lymphotoxin alpha and the lymphotoxin beta receptor.
    Taylor RT; Lügering A; Newell KA; Williams IR
    J Immunol; 2004 Dec; 173(12):7183-9. PubMed ID: 15585839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SMUCKLER/TIM4 is a distinct member of TIM family expressed by stromal cells of secondary lymphoid tissues and associated with lymphotoxin signaling.
    Shakhov AN; Rybtsov S; Tumanov AV; Shulenin S; Dean M; Kuprash DV; Nedospasov SA
    Eur J Immunol; 2004 Feb; 34(2):494-503. PubMed ID: 14768054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.